Mutual Recognition Amendment Promises Improved Pharma Inspection Practices
Dara Corrigan, FDA’s associate commissioner for global regulatory policy, called the agreement “an important step in working collaboratively and strategically with key partners to help ensure that American patients have access to safe, effective, and high-quality drugs.”
Leave a reply →
